AWINSA Life Sciences is a health care and pharmaceutical startup that aims to revolutionize the delivery of pharmacovigilance services. With a focus on both clinical trial and post-marketing services, the company prides itself on its meticulous approach to safety reports analysis, ensuring a clear understanding of clinical scenarios. Leveraging their deep-rooted expertise and understanding of international regulations, AWINSA Life Sciences promises top-notch services within strict timelines. Established in 2018, the startup's commitment to quality and astute analysis positions them as a promising player in the pharmaceutical industry. Currently, there are no public records regarding the company's headquarters, last investment, or investors. "Attitude to WIN with Sapience" encapsulates the company's ethos, portraying confidence and wisdom in their approach.
There is no investment information
No recent news or press coverage available for AWINSA Life Sciences.